KYTHERA Biopharmaceuticals announced the pricing of its initial public offering of 4,400,000 shares of its common stock at a price to the public of $16.00 per share. The shares of KYTHERA’s common stock will trade on the NASDAQ under the symbol “KYTH.” KYTHERA has granted the underwriters a 30-day option to purchase up to an additional 660,000 shares of common stock to cover over-allotmentsThe offering is expected to close on October 16, 2012J.